<DOC>
	<DOCNO>NCT01719692</DOCNO>
	<brief_summary>A comparative study rituximab ( 100 mg weekly 4 week 375mg/m2 ) show low dose rituximab may useful alternative therapy patient ITP.The aim study compare efficacy tolerability two different regimen low dos rituximab treatment adult patient ITP .</brief_summary>
	<brief_title>Low-dose Rituximab Regimens Chinese Adult Patients With Immune Thrombocytopenia</brief_title>
	<detailed_description>Hundreds Patients without infection ( age 18 60 year old ) develop Chronic ITP . All patient enrol study randomly assign receive 100 mg rituximab weekly 4 week ( group A ) single dose 375 mg/m2 rituximab ( group B ) . After treatment patient follow two year . During observation platelet count B lymphocyte detect every month .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Adult chronic ITP , age 18 60 pregnant woman ITP ; liver disease kidney disease ; allergy rituximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>